🟢 Icecure Medical is trading 6.1% up in after-hours trading on October 7 with no clear catalyst

Icecure Medical is trading 6.09% higher at $1.22 after closing the October 7 regular session at $1.15; no clear company-specific reason surfaced.

• The latest company announcement found was an October 6 update adding Legacy Health as a site in its FDA-approved ChoICE post-marketing study; it does not establish a cause for the move.
• The broader market was weaker on October 7, with no clear link to the rise; after-hours volume information was not provided.